Sanuwave Health EBITDA Margin 2010-2024 | SNWVD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Sanuwave Health (SNWVD) over the last 10 years. The current EBITDA margin for Sanuwave Health as of June 30, 2024 is .
| Sanuwave Health EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-06-30 |
$0.03B |
$0.01B |
36.00% |
| 2024-03-31 |
$0.02B |
$0.01B |
34.78% |
| 2023-12-31 |
$0.02B |
$0.01B |
33.33% |
| 2023-09-30 |
$0.02B |
$0.01B |
26.32% |
| 2023-06-30 |
$0.02B |
$0.00B |
16.67% |
| 2023-03-31 |
$0.02B |
$-0.00B |
-11.76% |
| 2022-12-31 |
$0.02B |
$-0.00B |
-18.75% |
| 2022-09-30 |
$0.02B |
$-0.00B |
-26.67% |
| 2022-06-30 |
$0.02B |
$-0.01B |
-33.33% |
| 2022-03-31 |
$0.01B |
$-0.01B |
-42.86% |
| 2021-12-31 |
$0.01B |
$-0.01B |
-69.23% |
| 2021-09-30 |
$0.01B |
$-0.02B |
-190.91% |
| 2021-06-30 |
$0.01B |
$-0.03B |
-312.50% |
| 2021-03-31 |
$0.01B |
$-0.03B |
-500.00% |
| 2020-12-31 |
$0.00B |
$-0.02B |
-800.00% |
| 2020-09-30 |
$0.00B |
$-0.01B |
-1400.00% |
| 2020-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2020-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2019-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2019-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2019-06-30 |
$0.00B |
$-0.01B |
-800.00% |
| 2019-03-31 |
$0.00B |
$-0.01B |
-700.00% |
| 2018-12-31 |
$0.00B |
$-0.01B |
-500.00% |
| 2018-09-30 |
$0.00B |
$-0.01B |
-500.00% |
| 2018-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2018-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2017-12-31 |
$0.00B |
$-0.00B |
inf% |
| 2017-09-30 |
$0.00B |
$-0.00B |
-400.00% |
| 2017-06-30 |
$0.00B |
$-0.00B |
-400.00% |
| 2017-03-31 |
$0.00B |
$-0.00B |
-400.00% |
| 2016-12-31 |
$0.00B |
$-0.00B |
-400.00% |
| 2016-09-30 |
$0.00B |
$-0.00B |
inf% |
| 2016-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2016-03-31 |
$0.00B |
$-0.00B |
inf% |
| 2015-12-31 |
$0.00B |
$-0.00B |
inf% |
| 2015-09-30 |
$0.00B |
$-0.00B |
inf% |
| 2015-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2015-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2014-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2014-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2014-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2014-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2013-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2013-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2013-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2013-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2012-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2012-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2012-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2012-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2011-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2011-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2011-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2011-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2010-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2010-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2009-12-31 |
$0.00B |
$-0.01B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.056B |
$0.020B |
|
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
|
